—— WHO WE ARE ——

We are the leader in the precision pathogen detection field with NGS

PANDx is a biotech company located in Singapore, specializing in R&D and production of IVD reagents, as well as molecular diagnostic solutions and detection services for infectious diseases. We provide integrated solutions for standardized pathogenic molecular detection via NGS. We can assist hospitals in building standardized pathogenic molecular detection platforms by integrating the whole process of closed-loop services including reagents, instruments, software and related applications, aiming to help healthcare organizations to build the capability of precise diagnostic and emerging pathogen surveillance. PANDx is to become a new pillar of mNGS and tNGS solutions in Asia.

In 2024, we tested over 500,000 samples, and 60% growth is expected to be maintained annually. In collaboration with clinical laboratory experts and partners, we have published more than 30 SCI articles in the field of microbiology and infection in the last three years.